Canadian healthtech company SaNOtize, led by Israeli co-founder and CEO Gilly Regev started its clinical trials in the U.K. for its new anti-Covid-19 nasal spray
Canadian healthtech company SaNOtize, led by Israeli co-founder and CEO Gilly Regev started its clinical trials in the U.K. for its new anti-Covid-19 nasal spray